Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Denver, Colorado 80220


Purpose:

Treatment of smokers with a tricyclic antidepressant, nortriptyline, can reduce tobacco withdrawal symptoms and increases long term cessation rates when combined with transdermal nicotine and a behavioral cessation programs. The study is a placebo-controlled, randomized, parallel group trial in which smokers aged 18-70 will be subject to the combination of oral and patch treatments.


Criteria:

Inclusion Criteria: - Aged 18-70, - smoking > 10 cigarettes per day, - no current major depression, - no concurrent psychiatric medications Exclusion Criteria:


NCT ID:

NCT00018148


Primary Contact:

Principal Investigator
Allan V. Prochazka, MD MSc
VA Eastern Colorado Health Care System, Denver


Backup Contact:

N/A


Location Contact:

Denver, Colorado 80220
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.